
Medpace Holdings (MEDP) Stock Forecast & Price Target
Medpace Holdings (MEDP) Analyst Ratings
Bulls say
Medpace Holdings is poised for growth, with expectations of passthrough revenues increasing by 200-300 basis points in the second half of the year compared to elevated levels in the second quarter. The company experienced a strong first quarter characterized by higher request for proposal (RFP) volumes, indicating robust demand in its sector. Furthermore, there is strong potential for Medpace’s book-to-bill ratio to return to above 1.15x in the third quarter, signaling a positive outlook for future revenues and operational performance.
Bears say
Medpace Holdings has exhibited signs of financial instability, as reflected in its backlog cancellations remaining at or above normal levels, although they have recently declined toward the lower end of expectations. Furthermore, the company has expressed uncertainty regarding the growth of its Direct Service revenue, indicating that it is premature to provide quantifiable forecasts, despite not anticipating a significant decline in 2026. Updated projections for adjusted EBITDA for 2025 and 2026 have increased, yet the adjustments appear to stem from rising direct service costs and an expected decrease in passthroughs, which may signal underlying operational challenges.
This aggregate rating is based on analysts' research of Medpace Holdings and is not a guaranteed prediction by Public.com or investment advice.
Medpace Holdings (MEDP) Analyst Forecast & Price Prediction
Start investing in Medpace Holdings (MEDP)
Order type
Buy in
Order amount
Est. shares
0 shares